More IMPs: Responses to the public consultations on new GMP Regulations published
More EMA publishes GVP Module V (Revision 2) for public comment
More EMA Guideline on the clinical evaluation of Factor VIII products published
More FDA Draft Guidance on NAT tests to reduce the risks of HBV transmission from cells and tissues
More New FDA Guidance on Completeness Assessements for Type II API Drug Master Files
More Already 13 EMA GMP Non-compliance Reports in 2016 published
More ECA publishes Code of Practice: The Responsible Person for GDP
More Non-Compliance Reports for European Manufacturers of Sterile Medicinal Products
More Chinese Heparin Manufacturer again involved in Falsification and GMP Non-Compliance
More Fraud and Major GMP Violations at API Manufacturers in India and China